Cryoport, Inc. (CYRX)
20.01
-0.16
(-0.79%)
USD |
NASDAQ |
Nov 19, 12:59
Cryoport Enterprise Value : 909.05M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 909.05M |
| November 17, 2026 | 887.25M |
| November 16, 2026 | 890.29M |
| November 13, 2026 | 894.85M |
| November 12, 2026 | 905.50M |
| November 11, 2026 | 928.81M |
| November 10, 2026 | 937.94M |
| November 09, 2026 | 924.25M |
| November 06, 2026 | 854.81M |
| November 05, 2026 | 700.22M |
| November 04, 2026 | 733.17M |
| November 03, 2026 | 720.49M |
| November 02, 2026 | 709.34M |
| October 30, 2026 | 763.07M |
| October 29, 2026 | 813.76M |
| October 28, 2026 | 831.50M |
| October 27, 2026 | 819.84M |
| October 26, 2026 | 788.41M |
| October 23, 2026 | 798.04M |
| October 22, 2026 | 790.44M |
| October 21, 2026 | 825.92M |
| October 20, 2026 | 770.67M |
| October 19, 2026 | 747.36M |
| October 16, 2026 | 740.26M |
| October 15, 2026 | 751.92M |
| Date | Value |
|---|---|
| October 14, 2026 | 730.12M |
| October 13, 2026 | 745.84M |
| October 12, 2026 | 740.26M |
| October 09, 2026 | 766.11M |
| October 08, 2026 | 743.30M |
| October 07, 2026 | 766.11M |
| October 06, 2026 | 788.92M |
| October 05, 2026 | 806.15M |
| October 02, 2026 | 770.17M |
| October 01, 2026 | 766.62M |
| September 30, 2026 | 768.65M |
| September 29, 2026 | 758.83M |
| September 28, 2026 | 761.87M |
| September 25, 2026 | 763.39M |
| September 24, 2026 | 762.88M |
| September 23, 2026 | 767.44M |
| September 22, 2026 | 771.49M |
| September 21, 2026 | 774.03M |
| September 18, 2026 | 743.64M |
| September 17, 2026 | 731.48M |
| September 16, 2026 | 717.81M |
| September 15, 2026 | 707.68M |
| September 14, 2026 | 689.95M |
| September 11, 2026 | 669.18M |
| September 10, 2026 | 655.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 56.52B |
| Protect Pharmaceutical Corp. | 3.287M |
| Champions Oncology, Inc. | 68.98M |
| Medpace Holdings, Inc. | 17.51B |
| Charles River Laboratories International, Inc. | 18.63B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.85M |
| Revenue (Quarterly) | 50.22M |
| Total Expenses (Quarterly) | 61.07M |
| EPS Diluted (Quarterly) | -0.2537 |
| Gross Profit Margin (Quarterly) | 40.89% |
| Profit Margin (Quarterly) | -21.61% |
| Earnings Yield | -4.49% |
| Normalized Earnings Yield | -4.193 |